Fda Concerns
- All
- News
- Videos
-
Elon Musk's Neuralink Says It Has FDA Approval for Study of Brain Implants in Humans
Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
-
Neuralink Said to Approach US Neurosurgery Centre as Potential Human Clinical Trials Partner
Neuralink, Elon Musk's brain implant company, is said to have approached one of the biggest US neurosurgery centres ahead of the company's plans to launch a human clinical trial for its devices that have been in development since 2016. The firm is working to address concerns expressed by the US Food and Drug Administration after it rejected an appl...
-
Starbucks Vanilla Frappuccino Bottles In US Recalled Over Health Safety Concerns
The US Food and Drug Administration said that more than 25,000 cases of the glass bottles have been recalled.
-
Maharashtra Cancels Johnson & Johnson's Baby Powder Licence Over Health Concerns
Maharashtra's Food and Drugs Administration (FDA) on Friday cancelled the baby powder manufacturing licence of Johnson & Johnson Pvt Ltd "in the interest of public health at large".
-
FDA Announces All Juul E-Cigarettes, Vaping Products Off Market Over Safety Concerns
The US Food and Drug Administration has ordered all vaping products produced by Juul Labs off the market after finding the former industry leader had failed to address certain safety concerns. Juul was blamed for a surge in youth vaping over its marketing of fruit and candy flavored e-cigarettes.
-
Regulator Asks 5 Firms To Recall Diabetes Drug Over Carcinogen Concerns
The US Food and Drug Administration (FDA) said on Thursday it has recommended five pharmaceutical firms to voluntarily recall their diabetes drug metformin after the agency found high levels of a possible cancer-causing impurity in some versions of the medication.
-
Google Knows You Better Than Your Doctor Ever Could
Ad networks like Google and Facebook track users all over the internet with cookies and device identifiers. Such tech companies know things that a person would never admit to a doctor. Read here to know more.
-
Johnson & Johnson Says It Gave Powder Samples To Regulators Over Carcinogen Concerns
Johnson & Johnson added that the safety of its cosmetic talc was based on a long history of safe use and decades of research and clinical evidence.
-
Sun Pharma Reports Surprise Drop In Profits
The company has spent months trying to resolve the concerns, but the FDA remains dissatisfied and outlined further problems with the plant in an inspection report in December.
-
Divi's Laboratories Slumps Over 30% In Just Two Days Over FDA Concerns
The Vizag plant is one of the biggest plants for Divi's. The company manufactures active pharmaceutical ingredients (APIs) and intermediates for generics among others at the Vizag manufacturing plant.
-
Sun Pharma Says US Finds More Concerns At Halol Plant
The latest notice, a Form 483, was issued to Sun after the FDA completed an inspection of the Halol plant on December 1, the company said.
-
Sun Pharma Says US Finds More Concerns At Halol Plant
The latest notice, a Form 483, was issued to Sun after the FDA completed an inspection of the Halol plant on December 1.
-
FDA Warns Former Sun Pharma US Drug Factory Over Quality Concerns
The US Food and Drug Administration has pulled up a former Sun Pharmaceutical drug factory for "knowingly" releasing 27 lots of the hypertension drug clonidine last year, despite proof that the raw materials used may have been contaminated.
-
Pharma Sector May Post Good Growth in Q4: Centrum Broking
The pharma sector is expected to report good growth for the fourth quarter of 2015-16 despite regulatory concerns raised by US Food and Drug Administration (FDA) and the recent ban on 344 fixed dose combinations imposed by the government, a report by Centrum Broking said.
-
Wockhardt Sinks 17% on Buzz of FDA Concern Over Shendra Plant
Wockhardt shares sank as much as 12.69 per cent to hit intraday low of Rs 1,323 on report that the pharmaceutical company has received a notice from US Food and Drug Administration for its drug manufacturing plant in Shendra, Maharashtra.
-
Elon Musk's Neuralink Says It Has FDA Approval for Study of Brain Implants in Humans
Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
-
Neuralink Said to Approach US Neurosurgery Centre as Potential Human Clinical Trials Partner
Neuralink, Elon Musk's brain implant company, is said to have approached one of the biggest US neurosurgery centres ahead of the company's plans to launch a human clinical trial for its devices that have been in development since 2016. The firm is working to address concerns expressed by the US Food and Drug Administration after it rejected an appl...
-
Starbucks Vanilla Frappuccino Bottles In US Recalled Over Health Safety Concerns
The US Food and Drug Administration said that more than 25,000 cases of the glass bottles have been recalled.
-
Maharashtra Cancels Johnson & Johnson's Baby Powder Licence Over Health Concerns
Maharashtra's Food and Drugs Administration (FDA) on Friday cancelled the baby powder manufacturing licence of Johnson & Johnson Pvt Ltd "in the interest of public health at large".
-
FDA Announces All Juul E-Cigarettes, Vaping Products Off Market Over Safety Concerns
The US Food and Drug Administration has ordered all vaping products produced by Juul Labs off the market after finding the former industry leader had failed to address certain safety concerns. Juul was blamed for a surge in youth vaping over its marketing of fruit and candy flavored e-cigarettes.
-
Regulator Asks 5 Firms To Recall Diabetes Drug Over Carcinogen Concerns
The US Food and Drug Administration (FDA) said on Thursday it has recommended five pharmaceutical firms to voluntarily recall their diabetes drug metformin after the agency found high levels of a possible cancer-causing impurity in some versions of the medication.
-
Google Knows You Better Than Your Doctor Ever Could
Ad networks like Google and Facebook track users all over the internet with cookies and device identifiers. Such tech companies know things that a person would never admit to a doctor. Read here to know more.
-
Johnson & Johnson Says It Gave Powder Samples To Regulators Over Carcinogen Concerns
Johnson & Johnson added that the safety of its cosmetic talc was based on a long history of safe use and decades of research and clinical evidence.
-
Sun Pharma Reports Surprise Drop In Profits
The company has spent months trying to resolve the concerns, but the FDA remains dissatisfied and outlined further problems with the plant in an inspection report in December.
-
Divi's Laboratories Slumps Over 30% In Just Two Days Over FDA Concerns
The Vizag plant is one of the biggest plants for Divi's. The company manufactures active pharmaceutical ingredients (APIs) and intermediates for generics among others at the Vizag manufacturing plant.
-
Sun Pharma Says US Finds More Concerns At Halol Plant
The latest notice, a Form 483, was issued to Sun after the FDA completed an inspection of the Halol plant on December 1, the company said.
-
Sun Pharma Says US Finds More Concerns At Halol Plant
The latest notice, a Form 483, was issued to Sun after the FDA completed an inspection of the Halol plant on December 1.
-
FDA Warns Former Sun Pharma US Drug Factory Over Quality Concerns
The US Food and Drug Administration has pulled up a former Sun Pharmaceutical drug factory for "knowingly" releasing 27 lots of the hypertension drug clonidine last year, despite proof that the raw materials used may have been contaminated.
-
Pharma Sector May Post Good Growth in Q4: Centrum Broking
The pharma sector is expected to report good growth for the fourth quarter of 2015-16 despite regulatory concerns raised by US Food and Drug Administration (FDA) and the recent ban on 344 fixed dose combinations imposed by the government, a report by Centrum Broking said.
-
Wockhardt Sinks 17% on Buzz of FDA Concern Over Shendra Plant
Wockhardt shares sank as much as 12.69 per cent to hit intraday low of Rs 1,323 on report that the pharmaceutical company has received a notice from US Food and Drug Administration for its drug manufacturing plant in Shendra, Maharashtra.
